# Universal Genetic Testing for Cancer Risk Reduction

> **NCT06926816** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 600 (estimated)

## Conditions studied

- Genetic Testing

## Interventions

- **GENETIC:** Natera® Empower™ hereditary cancer panel test
- **OTHER:** Specialist Referral

## Key facts

- **NCT ID:** NCT06926816
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-04
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926816, "Universal Genetic Testing for Cancer Risk Reduction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06926816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*